Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Operating expenses:        
Research and development $ 3,014,500 $ 5,335,500 $ 11,533,600 $ 13,340,300
General and administrative 2,948,300 1,856,800 6,004,500 5,494,100
Total operating expenses 5,962,800 7,192,300 17,538,100 18,834,400
Loss from operations (5,962,800) (7,192,300) (17,538,100) (18,834,400)
Other income (expenses), net:        
Interest income (expense), net 1,500 (1,800) 33,400 (6,800)
Loss on extinguishment of accounts payable 0 (22,700) 0 (22,700)
Loss before income taxes (5,961,300) (7,216,800) (17,504,700) (18,863,900)
Income taxes (200) 0 (2,600) (2,400)
Net loss and comprehensive loss (5,961,500) (7,216,800) (17,507,300) (18,866,300)
Accrued dividends on Series B Preferred stock (321,800) (290,900) (938,100) (848,000)
Net loss attributable to common stockholders $ (6,283,300) $ (7,507,700) $ (18,445,400) $ (19,714,300)
Basic and diluted net loss attributable to common stockholders per common share $ (.15) $ (0.24) $ (.43) $ (0.75)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share 43,158,889 30,696,312 42,802,256 26,418,440